Bifido Co. Ltd. (238200)
KRX SM KRX SM Primary Summary
238200 Chart
Bifido Co. Ltd. (238200) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Bifido Co. Ltd. ever had a stock split?
Bifido Co. Ltd. Profile
| Personal Care Products Industry | Consumer Staples Sector | - CEO | KRX SM Exchange | - ISIN |
| KR Country | 83 Employees | - Last Dividend | 1 Apr 2021 Last Split | - IPO Date |
Overview
BIFIDO Co., Ltd., established in 1999, specializes in the development and production of probiotics-based products. Operating both within South Korea and internationally, the company focuses on leveraging the beneficial properties of bifidobacterium strains to address various health concerns. Headquartered in Hongcheon-eup, South Korea, BIFIDO Co., Ltd. commits to enhancing gut health and overall wellness through its innovative probiotics solutions.
Products and Services
- BGN4
Designed for immune modulation, the BGN4 product utilizes specific bifidobacterium strains to help strengthen the body's immune response. It aims to provide support for the immune system through modulation, fostering overall health and resistance against illnesses.
- BORI
This product targets the treatment of rotavirus infection in infants. BORI is formulated with particular strains of bifidobacterium, providing a probiotic solution intended to combat and alleviate rotavirus-related symptoms in young children, thereby aiding in their recovery and promoting intestinal health.
- AD011
AD011 addresses general intestinal health problems by harnessing the power of specific bifidobacterium strains. It is designed to promote a healthy gut flora, supporting the overall wellness of the digestive system and contributing to improved gut health and functionality.
